Clinical Trials Directory

Trials / Completed

CompletedNCT02694484

Search Cytomegalovirus in Healthy Volunteers Stools Samples Selected as Potential Donor for Fecal Microbiota Transplant

Search Cytomegalovirus (CMV) in Healthy Volunteers Stools Samples Selected as Potential Donor for Fecal Microbiota Transplant

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
500 (actual)
Sponsor
University Hospital, Limoges · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Fecal microbiota transplantation (FMT) is recommended in the treatment of recurrent Clostridium difficile infection (CDI). The principle is to administer a fecal suspension of a healthy subject (donor) in the digestive tract of a patient with an CDI (receiver). Donors are being clinical and laboratory screening to reduce the likelihood of pathogens transmission (infectious and other). Cytomegalovirus (CMV) is part of the examinations requested by the Agence national de sécurité du médicament et des produits de santé in the context of clinical research. A sero-matching between donor and recipient CMV is requested. This recommendation eliminates many potential donors to a recipient. To date, the frequency detection level of CMV in stool in healthy volunteers with documented positive CMV serology is not known. In addition, CMV transmission risk via the stool is not established. This study aims to determine the detection frequency of CMV in healthy volunteers stool samples selected as potential donors for a FMT and having a positive CMV serology documented

Conditions

Interventions

TypeNameDescription
OTHERBlood and stool samplesBlood sample at Day 1 and blood and stool sample at the next visit

Timeline

Start date
2016-06-01
Primary completion
2017-07-01
Completion
2017-07-01
First posted
2016-02-29
Last updated
2025-07-20

Locations

5 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02694484. Inclusion in this directory is not an endorsement.